Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01139957 · ClinicalTrials.gov registry record
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
A clinical trial of Breast Carcinoma and Primary Peritoneal Carcinoma, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- 1,916
- Enrollment target
- 20
- Study locations
NCT01139957: Completed study of Breast Carcinoma and Primary Peritoneal Carcinoma, sponsored by Gynecologic Oncology Group.
NCT01139957 is a study of Breast Carcinoma and Primary Peritoneal Carcinoma that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 1,916 participants, above the 752-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (155% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01139957, a study of Breast Carcinoma and Primary Peritoneal Carcinoma, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- 1,916 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer. Gathering information about genetic factors in women with an increased risk of ovarian cancer over time may help doctors learn more about the disease and find better methods of treatment and on-going care.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- PROCEDURE Evaluation of Cancer Risk Factors
- PROCEDURE Study of High Risk Factors
Study Locations (20)
Connecticut
- Hartford Hospital - Hartford
- Smilow Cancer Hospital Care Center at Saint Francis - Hartford
- The Hospital of Central Connecticut - New Britain
- Yale University - New Haven
Florida
- Florida Gynecologic Oncology - Fort Myers
- Mayo Clinic in Florida - Jacksonville
- Sarasota Memorial Hospital - Sarasota
- Women's Cancer Associates - St. Petersburg
Illinois
- Rush University Medical Center - Chicago
- University of Chicago Comprehensive Cancer Center - Chicago
- NorthShore University HealthSystem-Evanston Hospital - Evanston
Arizona
- Gynecologic Oncology Group of Arizona - Phoenix
- Mayo Clinic in Arizona - Scottsdale
Delaware
- Beebe Medical Center - Lewes
- Christiana Care Health System-Christiana Hospital - Newark
Alabama
- University of Alabama at Birmingham Cancer Center - Birmingham
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Colorado
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,916 participants |
| Start Date | 2010-06-07 |
| Est. Completion | 2020-04-10 |
What the finished NCT01139957 record still lists
NCT01139957 is an observational study that tracks outcomes without assigning an intervention. Its 1,916 participants enrollment target places it among the larger protocols in the corpus, above the 752-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (155% higher).
The record links to 4 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT01139957 names 20 study sites across 10 states, led by Connecticut, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT01139957 about?
NCT01139957 is a clinical study titled "Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer". This clinical trial is studying the incidence of cancer in women at increased genetic risk of ovarian cancer. Gathering information about genetic factors in women with an increased risk of ovarian cancer over time may help doctors learn more about the disease and find better methods of treatment and...
What is the current status of trial NCT01139957?
This trial is currently completed. The enrollment target is 1,916 participants. The study started on 2010-06-07. Estimated completion is 2020-04-10.
What conditions does trial NCT01139957 study?
This clinical trial studies the following conditions: Breast Carcinoma, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma, Ovarian Neoplasm.
What interventions are being tested in trial NCT01139957?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Evaluation of Cancer Risk Factors (PROCEDURE), Study of High Risk Factors (PROCEDURE).
Who is sponsoring clinical trial NCT01139957?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01139957 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01139957's enrollment target sits among peer trials
1,916 10th of 106 higher than 97 of 106 other Breast Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RECRUITING · Phase 2
-
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
RECRUITING
-
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- NCT06799117 · 1,912 participants · NA
Adaptive Decision Support for Addiction Treatment Master
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI